All Pharma News
price-trendAsk Us
Big Pharma regained mojo in 2022 but biotechs remain precarious

Big Pharma regained mojo in 2022 but biotechs remain precarious
James Waldron FIERCE BIOTECH
03 Mar 2023
Share Share
The potential blockbusters still awaiting FDA decisions in 2021

The potential blockbusters still awaiting FDA decisions in 2021
FIERCEPHARMA
13 Sep 2021
Share Share
MMIT and Evaluate merge to become a $ 1.6 billion pharmaceutical market provider

MMIT and Evaluate merge to become a $ 1.6 billion pharmaceutical market provider
BUSINESSWIRE
29 Aug 2021
Share Share
Who`s getting the most out of their R&D engine? Pharma`s top 11, ranked

Who`s getting the most out of their R&D engine? Pharma`s top 11, ranked
Fraiser Kansteiner FIERCE PHARMA
26 Aug 2021
Share Share
Top 11 most valuable R&D engines in pharma

Top 11 most valuable R&D engines in pharma
Fraiser Kansteiner FIERCEPHARMA
24 Aug 2021
Share Share
Which pharma`s getting the most out of its new drug approvals?

Which pharma`s getting the most out of its new drug approvals?
FIERCE PHARMA
23 Aug 2021
Share Share
MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharma Market

MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharma Market
BUSINESSWIRE
20 Aug 2021
Share Share
Evaluate Group Limited Appoints Cem Baydar as Chief Consulting Officer

Evaluate Group Limited Appoints Cem Baydar as Chief Consulting Officer
BUSINESSWIRE
21 Jun 2021
Share Share